Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MC240703 Neuro-Oncology Anywhere: Glioma Home-Based Sequential Therapy (GHoST) Protocol

NCT07074756 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07074756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07074756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MC240703 Neuro-Oncology Anywhere: Glioma Home-Based Sequential Therapy (GHoST) Protocol
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Recruiting
Start date
September 12, 2025
Completion date
August 31, 2028
Enrollment
202 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glioma, recurrent glioblastoma, recurrent glioma